Smith & Nephew's Play in Image-Guided Surgery
Executive Summary
Quietly over the past several years, spinal implant leader Sofamor Danek (acquired by Medtronic Inc. ) has built a leadership position in image-guided surgery (IGS). The relevance to Sofamor Danek's core spinal business is clear: through enhanced visualization and navigation, spinal surgeons can perform complex cases that were once thought impossible and do more routine surgeries more quickly and easily. Now, Medtronic Sofamor Danek and Smith & Nephew PLC are teaming up to see if the benefits of IGS can extend to more traditional orthopedic segments.
You may also be interested in...
Smith & Nephew's Race to the Top
Guess who was the fastest growing orthopedic implant company last year. Smith & Nephew. The boom that has characterized the orthopedics market for the past several years has been a rising tide that lifts all boats--all, that is, except Smith & Nephew. But in the last couple of years, Smith & Nephew has actually been growing faster than their larger competitors. And in an industry that will increasingly see winners and losers, Smith & Nephew believes it is positioned to be one of the winners.
Smith & Nephew and Centerpulse: Perfect Together
While the deal between Smith & Nephew and Centerpulse may feel like the product of recent events, most notably Centerpulse's troubles, a closer look reveals the complementary nature of the two companies, showing the merger would have made sense in any case.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.